The next HPV vaccine approved in the United States, called Cervarix, is a bivalent vaccine that protects against HPV types 16 and 18 and was approved for use in females ages 9 to 26. Gardasil 9 ...

Gardasil ® (Merck) and Cervarix ® (GSK) have been positively evaluated in women up to 55 years of age. They are inducing robust responses in HIV-positive individuals. Gardasil has been used for ...

GSK says it plans to seek FDA approval for Cervarix by the end of the year. Early studies find that this vaccine, like Gardasil, is extremely safe and effective. GlaxoSmithKline is a WebMD sponsor.

have both been awarded a significant portion of the UNICEF HPV vaccine tender in order to provide the vaccinations. GSK is to provide a supply of Cervarix® (Human Papillomavirus vaccine [Types 16 ...

Gardasil-9 and Cervarix. Gardasil-9, which protects against nine types of HPV, is available for men and women, between the ages of nine and 45. Cervarix, approved for women aged nine to 45 ...

On the plus side, if GSK can show that Cervarix offers a more durable response than Gardasil, it could make substantial inroads into the latter's market share. As the vaccines market continues to ...